← back to search

Giordano Madeddu

Office of Infectious Diseases · IT
Area of research
Infectious Diseases · Emergency Medicine
Research interest
Research interests include HIV/AIDS drug development and treatment, HIV-related health complications and treatments, HIV Research and Treatment, and HIV/AIDS Research and Interventions.
h-index
41
citations
7,155
works
410
NIH funding
primary concept
email

Recent publications

Improving Tuberculosis Diagnosis Through Artificial Intelligence (CAD4TB) and Stool Xpert MTB/RIF Testing: A Prospective Study From Oromia, Ethiopia.
2026cited by 0position: contributordoi
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?
Clinical Microbiology and Infection 2025cited by 25position: lastdoi
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives
Infectious Disease Reports 2025cited by 22position: middledoi
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges
Viruses 2025cited by 16position: middledoi
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options
Antibiotics 2025cited by 15position: middledoi
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges.
2025cited by 9position: contributordoi
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options.
2025cited by 8position: contributordoi
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study
Infection 2025cited by 7position: middledoi
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives.
2025cited by 3position: contributordoi
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV.
2025cited by 3position: contributordoi
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation.
2025cited by 1position: contributordoi
Assessing the Accuracy, Completeness and Safety of ChatGPT-4o Responses on Pressure Injuries in Infants: Clinical Applications and Future Implications.
2025cited by 0position: contributordoi
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997-2022: Data From the Icona Cohort.
2025cited by 0position: contributordoi
Efficacy and Safety of Cabotegravir-Rilpivirine in PLWH: A Real-World Study.
2025cited by 0position: contributordoi
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists
Infection 2024cited by 29position: lastdoi
Fluoroquinolones and Biofilm: A Narrative Review
Pharmaceuticals 2024cited by 25position: middledoi
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity
AIDS and Behavior 2024cited by 23position: lastdoi
Fluoroquinolones and Biofilm: A Narrative Review.
2024cited by 13position: contributordoi
What do We Know about Cryptic Aspergillosis?
2024cited by 10position: contributordoi
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study.
2024cited by 8position: contributordoi
Knowledge, Attitudes, and Practices toward Antimicrobial Resistance among Young Italian Nurses and Students: A Multicenter, Cross-Sectional Study.
2024cited by 5position: contributordoi
Efficacy and Safety of Ceftazidime-Avibactam Alone versus Ceftazidime-Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort.
2024cited by 3position: contributordoi
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned?
2024cited by 2position: contributordoi
HBV in Italian Women's Jail: An Underestimated Problem?
2024cited by 1position: contributordoi
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country.
2024cited by 0position: contributordoi
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments
Antibiotics 2023cited by 65position: middledoi
Resistance in <i>Pseudomonas aeruginosa</i>: A Narrative Review of Antibiogram Interpretation and Emerging Treatments.
2023cited by 44position: contributordoi
Pillars of long-term antiretroviral therapy success
Pharmacological Research 2023cited by 20position: middledoi
Living with HIV and Getting Vaccinated: A Narrative Review.
2023cited by 14position: contributordoi
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era?
2023cited by 12position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 52 papers (2019–2026)Andrea De Vito · Elsevier, Inc.36 papers (2020–2025)Sergio Babudieri · Public Library of Science20 papers (2019–2024)Paolo Bonfanti · Azienda Ospedaliera Ospedale Civile di Legnano15 papers (2019–2024)Antonio Di Biagio · Polyclinic Medical Center15 papers (2019–2025)Elena Ricci · Università della Svizzera italiana12 papers (2019–2024)Vito Fiore · University of Sassari11 papers (2022–2024)Stefano Rusconi · Mylan (Switzerland)11 papers (2019–2023)Nicholas Geremia · AOL (United States)9 papers (2021–2025)Giuseppe Vittorio De Socio · University of Perugia9 papers (2019–2024)Benedetto Maurizio Celesia · Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi9 papers (2019–2025)Alessandra Bandera · ASST Fatebenefratelli Sacco7 papers (2019–2024)Emanuele Pontali · Agenzia Regionale per la Protezione dell'ambiente ligure7 papers (2020–2024)Lucia Taramasso · Polyclinic Medical Center7 papers (2019–2025)Agnese Colpani · Public Library of Science7 papers (2023–2025)Giovanni Pellicanò · Sapienza University of Rome7 papers (2019–2025)Andrea Calcagno · University of Milano-Bicocca7 papers (2019–2024) · 7 papers (2020–2025)Antonio Cascio · Department of Health6 papers (2019–2024)Sergio Lo Caputo · Policlinico Tor Vergata6 papers (2019–2025)